Stuttgart - Delayed Quote • EUR Valneva SE (AYJ.SG) Follow Compare 2.7200 +0.1800 +(7.09%) At close: January 31 at 4:35:06 PM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for AYJ.SG 1D 5D 19.51% 1M 27.22% 3M 0.59% 6M -16.31% YTD 27.22% 1Y -27.39% 5Y -12.26% All -52.72% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: AYJ.SG View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision High Growth Tech Stocks To Watch In January 2025 Valneva announces positive outcomes from chikungunya vaccine trial Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference VALNEVA Declaration of shares and voting rights: December 31, 2024 Exploring High Growth Tech Stocks for December 2024 Valneva and Serum Institute of India Collaborate to Tackle Chikungunya in Asia Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India